NHS vs Private Medicine in the UK: What Patients Need to Know
Many patients feel confused about the difference between NHS and private access to cannabis-based treatments in the UK.
While both pathways are legal, they operate very differently.
On the NHS, access is highly restricted. Treatments are only considered in a small number of cases, such as severe epilepsies, multiple sclerosis-related symptoms, or treatment-resistant nausea linked to chemotherapy. Even then, decisions are made by hospital specialists, and approvals are uncommon.
Private pathways are broader, but still regulated. Patients are assessed by specialist doctors who review diagnosis, treatment history, and overall health before making any decision. Not everyone will be eligible.
Key differences include:
• NHS access is limited to specific conditions
• Private assessments cover a wider range of cases
• Both require specialist doctor involvement
• Clinical judgement and safety guide decisions
Within services such as LeafEase, patients can explore private assessments through a structured process focused on suitability.
%20Cover%20(14).png)
Comments
Post a Comment